1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Biotechnology
CERo Therapeutics Holdings, Inc.

CERo Therapeutics Holdings, Inc.

CERO
CERo Therapeutics Holdings, Inc.US flagOther OTC
0.01
USD
+0.00
- -
14,464.00Market Cap

Income Statement (USD)

APIChatGPT
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2021
12/31/2022
12/31/2023
12/31/2024
12/31/2025
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
+ Sales & Services Revenue
- -
- -
- -
- -
- -
- Cost of Revenue
- -
- -
- -
- -
- -
+ Cost of Goods & Services
- -
- -
- -
- -
- -
Gross Profit
- -
- -
- -
- -
- -
+ Other Operating Income
- -
- -
- -
- -
- -
- Operating Expenses
12
12
8
- -
19
+ Selling, General & Admin
2
2
2
- -
9
+ Research & Development
9
10
5
- -
10
+ Other Operating Expense
- -
- -
- -
- -
- -
Operating Income (Loss)
-12
-12
-8
- -
-19
- Non-Operating (Income) Loss
-1
- -
- -
- -
1
+ Interest Expense, Net
-1
- -
- -
- -
- -
+ Interest Expense
- -
- -
- -
- -
- -
- Interest Income
1
- -
- -
- -
- -
+ Other Non-Op (Income) Loss
- -
- -
- -
- -
1
Pretax Income
-11
-12
-7
- -
-20
- Income Tax Expense (Benefit)
- -
- -
- -
- -
- -
- (Income) Loss from Affiliates
- -
- -
- -
- -
- -
Income (Loss) from Cont Ops
-11
-12
-7
- -
-20
- Net Extraordinary Losses (Gains)
- -
- -
- -
- -
- -
+ Discontinued Operations
- -
- -
- -
- -
- -
+ Extraord. & Accounting Changes
- -
- -
- -
- -
- -
Income (Loss) Incl. MI
-11
-12
-7
- -
-20
- Minority Interest
- -
- -
- -
- -
- -
Net Income, GAAP
-11
-12
-7
- -
-20
- Preferred Dividends
- -
- -
- -
- -
76
- Other Adjustments
- -
- -
- -
- -
- -
Net Income Avail to Common, GAAP
-11
-12
-7
- -
-95
EBIT
-12
-12
-8
- -
-19
EBITDA
-11
-11
-7
- -
-18
EBITDA Margin (%)
- -
- -
- -
- -
- -
EBITA
-12
-12
-8
- -
-19
Gross Margin (%)
- -
- -
- -
- -
- -
Operating Margin (%)
- -
- -
- -
- -
- -
Profit Margin (%)
- -
- -
- -
- -
- -
Sales per Employee
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
Depreciation Expense
1
1
1
- -
1
Basic Weighted Avg Shares
- -
- -
- -
- -
4
Basic EPS, GAAP
-2,345.98
-2,610.71
-1,222.26
- -
-22.56
Basic EPS from Cont Ops
-2,345.98
-2,610.71
-1,222.26
- -
-4.71
Diluted Weighted Avg Shares
- -
- -
- -
- -
4
Diluted EPS, GAAP
-2,345.98
-2,610.71
-1,222.26
- -
-22.56
Diluted EPS from Cont Ops
-2,345.98
-2,610.71
-1,222.26
- -
-4.71

Balance Sheet (USD)

APIChatGPT
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2021
12/31/2022
12/31/2023
12/31/2024
12/31/2025
Total Current Assets
20
7
2
4
3
+ Cash, Cash Equivalents & STI
19
7
2
3
2
+ Cash & Cash Equivalents
19
7
2
3
2
+ ST Investments
- -
- -
- -
- -
- -
+ Accounts & Notes Receiv
- -
- -
- -
- -
- -
+ Accounts Receivable, Net
- -
- -
- -
- -
- -
+ Notes Receivable, Net
- -
- -
- -
- -
- -
+ Loans Receivable, Net
- -
- -
- -
- -
- -
+ Other Receivable, Net
- -
- -
- -
- -
- -
+ Inventories
- -
- -
- -
- -
- -
+ Raw Materials
- -
- -
- -
- -
- -
+ Work In Process
- -
- -
- -
- -
- -
+ Finished Goods
- -
- -
- -
- -
- -
+ Inventory Adjustments
- -
- -
- -
- -
- -
+ Other Inventory
- -
- -
- -
- -
- -
+ Other ST Assets
- -
- -
- -
- -
1
+ Misc ST Assets
- -
- -
- -
- -
- -
+ Prepaid Expenses
- -
- -
- -
- -
- -
+ ST Derivative & Hedging Assets
- -
- -
- -
- -
- -
+ ST Assets Held-for-Sale
- -
- -
- -
- -
- -
+ ST Deferred Tax Assets
- -
- -
- -
- -
- -
Total Noncurrent Assets
5
4
3
2
1
+ Property, Plant & Equip, Net
5
4
3
2
1
+ Property, Plant & Equip
5
5
5
4
3
- Accumulated Depreciation
1
1
2
2
2
+ LT Investments & Receivables
- -
- -
- -
- -
- -
+ LT Investments
- -
- -
- -
- -
- -
+ LT Receivables
- -
- -
- -
- -
- -
+ Other LT Assets
- -
- -
- -
- -
- -
+ Total Intangible Assets
- -
- -
- -
- -
- -
+ Goodwill
- -
- -
- -
- -
- -
+ Other Intangible Assets
- -
- -
- -
- -
- -
+ LT Deferred Tax Assets
- -
- -
- -
- -
- -
+ LT Derivative & Hedging Assets
- -
- -
- -
- -
- -
+ Misc LT Assets
- -
- -
- -
- -
- -
Total Assets
24
11
5
6
4
+ Payables & Accruals
- -
- -
2
6
8
+ Accounts Payable
- -
- -
2
5
8
+ Accrued Taxes
- -
- -
- -
- -
- -
+ Interest & Dividends Payable
- -
- -
- -
- -
- -
+ Other Payables & Accruals
- -
- -
- -
2
1
+ ST Debt
1
1
1
1
1
+ ST Borrowings
- -
- -
1
- -
- -
+ ST Finance Leases
1
1
1
1
1
+ Other ST Liabilities
1
- -
- -
- -
- -
+ Deferred Revenue
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
+ Misc ST Liabilities
1
- -
- -
- -
- -
Total Current Liabilities
2
1
4
7
9
+ LT Debt
3
2
2
1
- -
+ LT Borrowings
- -
- -
- -
- -
- -
+ LT Finance Leases
3
2
2
1
- -
+ Other LT Liabilities
43
43
42
- -
- -
+ Accrued Liabilities
- -
- -
- -
- -
- -
+ Pension Liabilities
- -
- -
- -
- -
- -
+ Deferred Revenue
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
+ Misc LT Liabilities
43
43
42
- -
- -
Total Noncurrent Liabilities
46
45
44
1
- -
Total Liabilities
48
46
47
8
9
+ Preferred Equity and Hybrid Capital
- -
- -
- -
3
7
+ Share Capital & APIC
1
1
1
67
78
+ Common Stock
- -
- -
- -
- -
- -
+ Additional Paid in Capital
1
1
1
67
78
- Treasury Stock
- -
- -
- -
- -
- -
+ Retained Earnings
-24
-36
-43
-71
-91
+ Other Equity
- -
- -
- -
- -
- -
Equity Before Minority Interest
-23
-35
-42
-2
-5
+ Minority/Non Controlling Interest
- -
- -
- -
- -
- -
Total Equity
-23
-35
-42
-2
-5
Total Liabilities & Equity
24
11
5
6
4
Shares Outstanding
- -
- -
- -
- -
21
Number of Employees
- -
- -
- -
- -
- -
Capital Leases - Total
4
3
2
2
1
Net Debt
-19
-7
-1
-3
-2
Net Debt to Equity
82.03
19.56
2.38
175.61
30.52
Tangible Common Equity Ratio
-96.91
-307.25
-820.43
-81.7
-349.06
Current Ratio
10.62
6.08
0.56
0.5
0.3
Cash Conversion Cycle
- -
- -
- -
- -
- -

Cash Flow Statement (USD)

APIChatGPT
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2021
12/31/2022
12/31/2023
12/31/2024
12/31/2025
+ Net Income
-11
-12
-7
- -
-20
+ Depreciation & Amortization
1
1
1
- -
1
+ Non-Cash Items
-1
- -
- -
- -
3
+ Stock-Based Compensation
- -
- -
- -
- -
2
+ Deferred Income Taxes
- -
- -
- -
- -
- -
+ Asset Impairment Charge
- -
- -
- -
- -
1
+ Other Non-Cash Adj
-1
- -
- -
- -
- -
+ Chg in Non-Cash Work Cap
- -
-1
1
- -
- -
+ (Inc) Dec in Accts Receiv
- -
- -
- -
- -
- -
+ (Inc) Dec in Inventories
- -
- -
- -
- -
- -
+ (Inc) Dec in Prepaid Assets
- -
- -
- -
- -
-1
+ Inc (Dec) in Accts Payable
1
-1
1
- -
2
+ Inc (Dec) in Other
- -
-1
-1
- -
-1
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
Cash from Operating Activities
-10
-12
-6
- -
-16
+ Change in Fixed & Intang
- -
- -
- -
- -
- -
+ Disp in Fixed & Intang
- -
- -
- -
- -
- -
+ Disp of Fixed Prod Assets
- -
- -
- -
- -
- -
+ Disp of Intangible Assets
- -
- -
- -
- -
- -
+ Acq of Fixed & Intang
-1
-1
- -
- -
- -
+ Acq of Fixed Prod Assets
-1
-1
- -
- -
- -
+ Acq of Intangible Assets
- -
- -
- -
- -
- -
+ Cash (Repurchase) of Equity
- -
- -
- -
- -
1
+ Increase in Capital Stock
- -
- -
- -
- -
1
+ Decrease in Capital Stock
- -
- -
- -
- -
- -
+ Net Change in LT Investment
- -
- -
- -
- -
- -
+ Dec in LT Investment
- -
- -
- -
- -
- -
+ Inc in LT Investment
- -
- -
- -
- -
- -
+ Net Cash From Acq & Div
- -
- -
- -
- -
- -
+ Cash from Divestitures
- -
- -
- -
- -
- -
+ Cash for Acq of Subs
- -
- -
- -
- -
- -
+ Cash for JVs
- -
- -
- -
- -
- -
+ Other Investing Activities
- -
- -
- -
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
Cash from Investing Activities
-1
-1
- -
- -
- -
+ Dividends Paid
- -
- -
- -
- -
- -
+ Net Cash From Debt
- -
- -
1
- -
- -
+ Cash From Debt
- -
- -
1
- -
- -
+ Repayments of Debt
- -
- -
- -
- -
- -
+ Other Financing Activities
- -
- -
- -
- -
13
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
Cash from Financing Activities
- -
- -
1
- -
14
Effect of Foreign Exchange Rates
- -
- -
- -
- -
- -
Net Changes in Cash
-11
-12
-5
- -
-2
EBITDA
-11
-11
-7
- -
-18
EBITDA Margin (%)
- -
- -
- -
- -
- -
Free Cash Flow
-11
-12
-6
- -
-16
Net Cash Paid for Acquisitions
- -
- -
- -
- -
- -
Free Cash Flow to Firm
- -
- -
- -
- -
- -
Free Cash Flow to Equity
- -
-12
-5
3
-88
Free Cash Flow per Basic Share
-2,363.04
-2,737.48
-970.82
- -
-3.8
Price/Free Cash Flow
-9.47
-8.45
-22.66
- -
-0.02
Cash Flow to Net Income
0.95
0.99
0.79
- -
0.81
Capital Expenditures
-1
-1
- -
- -
- -